Evidence map›Paper›PMID 24533173›Full record

ArticleCartilage2013

Effects of Dexamethasone on Mesenchymal Stromal Cell Chondrogenesis and Aggrecanase Activity: Comparison of Agarose and Self-Assembling Peptide Scaffolds.

Emily M Florine, Rachel E Miller, Ryan M Porter, Christopher H Evans, Bodo Kurz, Alan J Grodzinsky

Open access · greenAbstract read
In one paragraph

Article in Cartilage, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Glucocorticoid Effects on Proteoglycans and Glycosaminoglycans.International journal of molecular sciences · 2022
    Review
  5. Article
  6. Review
  7. Article
  8. Role of dexamethasone in the long-term functional maturation of MSC-laden hyaluronic acid hydrogels for cartilage tissue engineering.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2018
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Evaluation of culture conditions forConnective tissue research
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Emily M FlorineDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA.
Rachel E MillerDepartment of Biochemistry and Section of Rheumatology, Rush University Medical Center, Chicago, IL.
Ryan M PorterCenter for Advanced Orthopedic Studies, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Christopher H EvansCenter for Advanced Orthopedic Studies, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Bodo KurzBond University, Gold Coast, Australia and Anatomical Institute, University of Kiel, Germany.
Alan J GrodzinskyCenter for Biomedical Engineering, Massachusetts Institute of Technology, Cambridge, MA.
Beth Israel Deaconess Medical Center · USMassachusetts Institute of Technology · USKiel University · DERush University Medical Center · US

Funding

Self-Assembling Peptides for Tissue EngineeringR01EB003805 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GRODZINSKY, ALAN J. · 2005 to 2009
$6.5M
Cartilage Repair Using Self Assembling Peptide ScaffoldsR01AR060331 · NIAMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GRODZINSKY, ALAN J. · 2012 to 2016
$1.7M
Facilitating cartilage regeneration by heterogeneous progenitor cellsR00AR057105 · NIAMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI PORTER, RYAN MICHAEL · 2011 to 2013
$726k
NIAMS NIH HHS R01 AR060331NIBIB NIH HHS R01 EB003805
6 · The paper itself

Abstract

objectiveDexamethasone (Dex) is a synthetic glucocorticoid that has pro-anabolic and anti-catabolic effects in cartilage tissue engineering systems, though the mechanisms by which these effects are mediated are not well understood. We tested the hypothesis that the addition of Dex to chondrogenic medium would affect matrix production and aggrecanase activity of human and bovine bone marrow stromal cells (BMSCs) cultured in self-assembling peptide and agarose hydrogels.

designWe cultured young bovine and adult human BMSCs in (RADA)

resultsDex improved proteoglycan synthesis and retention in agarose hydrogels seeded with young bovine cells, but decreased proteoglycan accumulation in peptide scaffolds. These effects were mediated by the glucocorticoid receptor. Adult human BMSCs showed minimal matrix accumulation in agarose, but accumulated ~50% as much proteoglycan and collagen as young bovine BMSCs in peptide hydrogels. Dex reduced aggrecanase activity in (RADA)

conclusionsThe effects of Dex on matrix production are dependent on cell source and hydrogel identity. This is the first report of Dex reducing aggrecanase activity in a tissue engineering culture system.

Indexed as

articular cartilageChondrogenesisdegradative enzymesextracellular matrixmesenchymal stem cells

Identifiers

PMID24533173
PMCPMC3922645
OpenAlexW2173410376

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.